Tsutomu Yoshida Selected Research

Lasers (Laser)

1/2009	Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: relation to age and gender.
1/2008	Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis.
12/2006	Genetic instability on chromosome 17 in the epithelium of non-polypoid colorectal carcinomas compared to polypoid lesions.
10/2003	High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis-associated carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsutomu Yoshida Research Topics

Disease

24	Neoplasms (Cancer) 01/2024 - 11/2002
11	Ulcerative Colitis 01/2023 - 05/2003
10	Carcinoma (Carcinomatosis) 01/2020 - 03/2002
9	Adenocarcinoma 12/2022 - 05/2003
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 10/2003
6	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2003
4	Adenocarcinoma of Lung 03/2021 - 09/2006
4	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2009
4	Colitis 03/2019 - 10/2002
4	Carcinogenesis 08/2012 - 10/2003
4	Adenoma (Adenomas) 05/2011 - 05/2003
3	Disease Progression 02/2024 - 01/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 04/2019
3	Microsatellite Instability 10/2022 - 10/2003
3	Lymphatic Metastasis 09/2021 - 11/2011
3	Endometrial Neoplasms (Endometrial Cancer) 11/2013 - 01/2003
2	Neoplasm Metastasis (Metastasis) 02/2024 - 10/2017
2	Residual Neoplasm 05/2023 - 01/2006
2	Stomach Neoplasms (Stomach Cancer) 12/2022 - 10/2017
2	Hypoxia (Hypoxemia) 08/2020 - 11/2013
2	Lymphoma (Lymphomas) 05/2020 - 01/2010
2	Leukopenia 10/2017 - 01/2003
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2015 - 01/2010
2	Hyperplasia 01/2014 - 01/2003
2	Radiation Pneumonitis 11/2013 - 11/2010
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2013 - 11/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012 - 03/2011
1	Prostatic Neoplasms (Prostate Cancer) 02/2024
1	Pediatric ulcerative colitis 01/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2022
1	Exanthema (Rash) 10/2022
1	Pathologic Complete Response 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 12/2021
1	Triple Negative Breast Neoplasms 09/2021
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Multiple Myeloma 05/2021
1	Lymphadenopathy 01/2021
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Ulcer 03/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2019 - 03/2002
7	ErbB Receptors (EGF Receptor)IBA 03/2021 - 09/2006
4	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 02/2003
4	Formaldehyde (Formol)FDA Link 04/2019 - 01/2006
4	Messenger RNA (mRNA)IBA 03/2019 - 01/2006
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2008
3	Amino Acid Transport Systems (Amino Acid Transporter)IBA 09/2021 - 05/2011
3	ParaffinIBA 04/2019 - 01/2006
3	Dextran SulfateIBA 03/2019 - 10/2002
3	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 03/2009
3	beta CateninIBA 04/2011 - 01/2003
2	pembrolizumabIBA 12/2022 - 10/2022
2	B7-H1 AntigenIBA 12/2022 - 01/2018
2	Therapeutic UsesIBA 10/2022 - 01/2003
2	Gefitinib (Iressa)FDA Link 10/2022 - 12/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 09/2021 - 01/2003
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2021 - 01/2019
2	AntigensIBA 02/2019 - 04/2011
2	Cadherins (E-Cadherin)IBA 01/2018 - 03/2007
2	Keratins (Keratin)IBA 01/2018 - 01/2009
2	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 10/2003
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2004
2	Cyclin EIBA 01/2014 - 01/2006
2	CateninsIBA 01/2014 - 11/2013
2	Cyclin D1IBA 01/2014 - 01/2006
2	Transcription Factors (Transcription Factor)IBA 08/2012 - 01/2010
2	Butyric Acid (Butanoic Acid)IBA 03/2011 - 03/2006
2	NF-kappa B (NF-kB)IBA 01/2010 - 05/2009
2	CytokinesIBA 05/2009 - 08/2006
1	Indicators and Reagents (Reagents)IBA 01/2024
1	11 alpha- hydroxy- 9,15- dioxo- 2,3,4,5,20- pentanor- 19- carboxyprostanoic acidIBA 01/2023
1	ProstaglandinsIBA 01/2023
1	NivolumabIBA 01/2022
1	LigandsIBA 01/2022
1	human ERBB2 proteinIBA 09/2021
1	Bortezomib (Velcade)FDA Link 05/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 08/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2020
1	Protein Kinases (Protein Kinase)IBA 05/2020
1	MucinsIBA 07/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2019
1	CarbohydratesIBA 02/2019
1	Peptides (Polypeptides)IBA 01/2019
1	angiogeninIBA 01/2019
1	Olanzapine (Zyprexa)FDA Link 01/2019

Therapy/Procedure

9	Therapeutics 02/2024 - 01/2003
7	Drug Therapy (Chemotherapy) 08/2019 - 01/2003
5	Radiotherapy 01/2016 - 10/2003
4	Chemoradiotherapy 01/2022 - 10/2003
4	Lasers (Laser) 01/2009 - 10/2003
2	Punctures 01/2024 - 05/2023
2	Combination Drug Therapy (Combination Chemotherapy) 10/2017 - 03/2009
1	Castration 02/2024
1	Laryngoscopes 12/2021
1	Ligation 04/2019
1	Precision Medicine 04/2019